High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional)
ID: 357548Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357548

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-25-001.html
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Dec 5, 2024, 12:00 AM UTC
  4. 4
    Due Jun 6, 2025, 12:00 AM UTC
Description

The National Institutes of Health (NIH) is offering a funding opportunity for "High-Priority Research in Tobacco Regulatory Science" aimed at advancing scientific understanding of tobacco products to inform regulations by the Food and Drug Administration (FDA). This initiative invites R01 applications focused on critical research areas, including addiction, health impacts, and the toxicity of electronic nicotine delivery systems (ENDS) and other tobacco products. The funding is crucial for generating data that will guide FDA's regulatory decisions, ultimately protecting public health. Each application can request up to $500,000 per year for a project period of up to five years, with a total of $4 million available across five awards. Applications are due by June 7, 2025, and interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.

Point(s) of Contact
grantsinfo@nih.gov
Files
Title
Posted
RFA-OD-25-001.html
Dec 6, 2024, 11:48 AM UTC
The Department of Health and Human Services, through the NIH, is offering funding for "High-Priority Research in Tobacco Regulatory Science" aimed at advancing scientific knowledge about tobacco products to inform FDA regulations. This Notice of Funding Opportunity (NOFO) encourages R01 applications focused on critical research areas such as addiction, behavioral effects, health impacts, product composition, and toxicity related to electronic nicotine delivery systems (ENDS) and other tobacco products. The maximum budget for each application is $500,000 per year for a project period of up to five years, with a total of up to $4 million available across five awards. Importantly, a Plan for Enhancing Diverse Perspectives (PEDP) is required for applications, stressing the value of diverse viewpoints in research and requiring clear strategies for inclusion. The submission timeline includes an application opening on May 6, 2025, with a due date of June 7, 2025. This initiative emphasizes the significance of high-priority research to guide FDA's decision-making processes regarding tobacco product marketing, health effects, and regulatory compliance, ultimately aiming to protect public health.
Similar Opportunities
Tobacco Regulatory Science (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is inviting applications for the "Tobacco Regulatory Science (R01 Clinical Trial Optional)" funding opportunity, aimed at supporting biomedical and behavioral research to inform the regulation of tobacco products and protect public health. This initiative seeks R01 research project grant applications that address key research priorities, including the composition and design of tobacco products, toxicity assessments, addiction studies, and the health effects of tobacco use. A total of up to six R01 grants, with a combined funding of $4 million for fiscal year 2024, will be awarded to eligible applicants, which include a diverse range of institutions and organizations. Interested parties should submit their applications by May 4, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-23-017.html for further details.
Notice of Intent to Publish a Notice of Funding Opportunity (NOFO) for High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for High-Priority Research in Tobacco Regulatory Science, inviting R01 research applications that focus on biomedical and behavioral research to inform tobacco product regulation. This initiative aims to generate scientific data that will enhance public health protections related to tobacco use, with a particular emphasis on fostering diverse perspectives through a simplified peer review framework. The total estimated funding for this program is $4 million, with an award ceiling of $500,000 for each of the anticipated five awards, and the NOFO is expected to be published in Winter 2024, with applications due in Summer 2025. Interested applicants should prepare to submit new applications, as only new proposals will be considered, and further details will be available upon the official release of the NOFO.
Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)" aimed at supporting research projects that evaluate policies related to tobacco, alcohol, and cannabis use in the United States. The initiative focuses on understanding how these policies impact substance use and secondhand exposure among populations experiencing health disparities, with an emphasis on community engagement to enhance cancer prevention efforts. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and government entities, with funding available up to $500,000 per year for a maximum of five years. Interested parties can find more information and application details at the NIH grants website, with the application deadline set for January 7, 2028.
Data Standards for Tobacco Research and Scientific Review Phase 2
Food and Drug Administration
The Food and Drug Administration (FDA) is forecasting a cooperative agreement opportunity titled "Data Standards for Tobacco Research and Scientific Review Phase 2," aimed at enhancing tobacco research and improving public health outcomes related to tobacco use. The primary objective of this initiative is to develop open, consensus-based data standards for studies on tobacco products, while also promoting education on standardized data usage among federal regulators, the tobacco industry, and global organizations. This funding opportunity, categorized under consumer protection, has an estimated total program funding of $400,000, with two awards expected to be granted. Interested applicants, particularly small businesses, should note that the synopsis is anticipated to be posted on October 1, 2023, with a closing date of December 1, 2023, and projects are expected to commence on May 1, 2024. For further inquiries, applicants can contact Rene A. Vasquez, Grants Management Specialist, at 301-796-3546 or via email at rene.vasquez@fda.hhs.gov.
Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity titled "Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)" aimed at supporting policy research projects that investigate the impact of tobacco, alcohol, and cannabis policies on health disparities in the U.S. The initiative seeks exploratory research that engages community organizations to promote equity in cancer prevention by addressing substance use and exposure among disadvantaged populations. This grant program, with an estimated total funding of $200,000 and an award ceiling of $200,000, emphasizes the importance of community partnerships and diverse research team perspectives. Applications are due by January 7, 2028, and interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-241.html.
Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for research projects focused on health equity related to tobacco, alcohol, and cannabis policies. This initiative aims to address disparities in exposure and use of these substances by examining new or adapted policies in the U.S., with the goal of advancing equitable health policies. The funding opportunity will utilize the R01 grant mechanism, which is optional for clinical trials, and is expected to open for applications in February 2025, with a funding ceiling of $499,999. Interested applicants should prepare their proposals in advance, as the NOFO is anticipated to be published in September 2024, and further details, including a pre-application webinar, will be announced following the publication.
Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for pilot and exploratory research projects focused on health equity related to tobacco, alcohol, and cannabis use. The initiative aims to investigate disparities in exposure and usage of these substances by examining new or adapted policies in the U.S., with the goal of advancing equitable health policies. This funding opportunity will utilize the R21 grant mechanism, which supports early-stage research, and is expected to be published in September 2024, with the first application deadline in March 2025. Interested applicants should prepare their proposals in advance, as the estimated award date is December 1, 2025, and further details, including a pre-application webinar, will be announced following the NOFO publication.
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity titled "High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)" aimed at supporting innovative research that addresses the intersection of HIV and substance use. This initiative invites applications from individual researchers and research teams to develop projects that can lead to new prevention, treatment, and care strategies for individuals affected by both conditions, with a requirement for a detailed research plan and preliminary data. A total budget of $3.0 million is available for funding one to two awards, with individual project budgets capped at $1.5 million per fiscal year, and applications are due by February 12, 2027. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to consult with NIDA program staff early in the application process.
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity titled "Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders" (R34 Clinical Trial Optional). This initiative encourages pilot studies aimed at preparing for larger-scale effectiveness trials that focus on optimizing access, quality, and affordability of substance use disorder treatments and related services, with an emphasis on diverse perspectives through a Plan for Enhancing Diverse Perspectives (PEDP). Applicants may request up to $450,000 in direct costs for a three-year grant, with application due dates beginning January 16, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-100.html.
Integrated Functional Mapping and Molecular Profiling of Cell Ensembles Encoding the Effects of Addictive Substances in Rodents (R01 Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH), through its National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "Integrated Functional Mapping and Molecular Profiling of Cell Ensembles Encoding the Effects of Addictive Substances in Rodents." This initiative aims to support innovative research that utilizes scalable technologies to investigate the cellular responses associated with substance use disorders in rodent models, focusing on integrating neural activity metrics with molecular profiles to enhance understanding of addiction-related neurobehavioral processes. The total funding available is $2 million, with individual grants not exceeding $700,000 in direct costs per year for a project period of up to five years, and proposals must adhere to NIH’s data sharing policies. Interested applicants can find more information and submit inquiries via email to grantsinfo@nih.gov, with the application deadline set for February 23, 2026.